Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling
Germany
11720697.9
Filed on 2011-05-11
11720697.9
Filed on 2011-05-11
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Japan
198519/2016
Filed on 2016-10-06
198519/2016
Filed on 2016-10-06
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1
US Patent 10,251,912
Filed on 2016-08-19
Filed on 2016-08-19
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Sweden
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Norway
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
The Netherlands
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Italy
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
United Kingdom
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04
Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
France
03794636.5
Filed on 2005-04-04
03794636.5
Filed on 2005-04-04